Texas Oncology-Fort Worth Cancer Center — Fort Worth, Texas

Texas Oncology-Fort Worth Cancer Center is a clinical research site located in Fort Worth, Texas, United States 76104.

Crixeo Clinical Trials Trust Score: 25/100 (FAILING). This profile has not yet been claimed by the site owner.

Texas Oncology-Fort Worth Cancer Center has participated in 44 clinical trials with 15 currently active.

Therapeutic areas: Melanoma, Non-small Cell Lung Cancer, Squamous Cell Carcinoma of the Head and Neck.

Sponsors: Seagen, a wholly owned subsidiary of Pfizer, Gynecologic Oncology Group, K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Fort Worth

Browse all research sites in Texas · View every site in Fort Worth

Sponsor Feasibility Report

Trust Score: 25/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Texas Oncology-Fort Worth Cancer Center?

Texas Oncology-Fort Worth Cancer Center has a Crixeo Trust Score of 25/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Texas Oncology-Fort Worth Cancer Center conducted?

Texas Oncology-Fort Worth Cancer Center has 44 clinical trials on record, with 15 currently active. Their work covers Melanoma, Non-small Cell Lung Cancer, Squamous Cell Carcinoma of the Head and Neck.

Is Texas Oncology-Fort Worth Cancer Center accredited by Crixeo Clinical Trials?

Texas Oncology-Fort Worth Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Texas Oncology-Fort Worth Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.